Difference between revisions of "Upper tract urothelial carcinoma"

From Libre Pathology
Jump to navigation Jump to search
(Created page with "'''Upper tract urothelial carcinoma''', is urothelial carcinoma that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.<ref>{{ci...")
 
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Upper tract urothelial carcinoma''', is [[urothelial carcinoma]] that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.<ref>{{cite journal |authors=Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R |title=Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma |journal=Can Urol Assoc J |volume=7 |issue=9-10 |pages=306–11 |date=2013 |pmid=24319507 |pmc=3854466 |doi=10.5489/cuaj.1578 |url=}}/ref>
'''Upper tract urothelial carcinoma''' (abbreviated '''UTUC'''), is a [[urothelial carcinoma]] that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.<ref name=pmid24319507>{{cite journal |authors=Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R |title=Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma |journal=Can Urol Assoc J |volume=7 |issue=9-10 |pages=306–11 |date=2013 |pmid=24319507 |pmc=3854466 |doi=10.5489/cuaj.1578 |url=}}</ref>


==General==
==General==
*Low-grade UCC may be managed via endoscopic approaches.<ref>{{cite journal |authors=Argyropoulos AN, Tolley DA |title=Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches |journal=BJU Int |volume=99 |issue=5 |pages=982–7 |date=May 2007 |pmid=17437430 |doi=10.1111/j.1464-410X.2007.06870.x |url=}}</ref>
*Low-grade upper tract urothelial carcinoma may be managed via endoscopic approaches.<ref name=pmid17437430>{{cite journal |authors=Argyropoulos AN, Tolley DA |title=Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches |journal=BJU Int |volume=99 |issue=5 |pages=982–7 |date=May 2007 |pmid=17437430 |doi=10.1111/j.1464-410X.2007.06870.x |url=}}</ref>
*May be associated with [[Lynch syndrome]] - [[MMR testing]] typically indicated.


==See also==
==See also==
Line 10: Line 11:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Urologic pathology]]
[[Category:Urothelium]]

Latest revision as of 18:34, 3 September 2024

Upper tract urothelial carcinoma (abbreviated UTUC), is a urothelial carcinoma that involves the upper urinary tract (ureter, pelvis, kidney). It is a considered a rare disease.[1]

General

  • Low-grade upper tract urothelial carcinoma may be managed via endoscopic approaches.[2]
  • May be associated with Lynch syndrome - MMR testing typically indicated.

See also

References

  1. Kapoor A, Allard CB, Black P, Kassouf W, Morash C, Rendon R (2013). "Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma". Can Urol Assoc J 7 (9-10): 306–11. doi:10.5489/cuaj.1578. PMC 3854466. PMID 24319507. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854466/.
  2. Argyropoulos AN, Tolley DA (May 2007). "Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches". BJU Int 99 (5): 982–7. doi:10.1111/j.1464-410X.2007.06870.x. PMID 17437430.